Cart
sales@molnova.com
HBF-0259
CAS No. 957011-15-3
HBF-0259( HBF 0259 | HBF0259 )
Catalog No. M27882 CAS No. 957011-15-3
HBF-0259 is an inhibitors of hepatitis B virus surface antigen (HBsAg) secretion with an EC50 of 11.3 μM and a CC50 value of >50 μM in HepG2.2.15 cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 69 | Get Quote |
|
| 5MG | 115 | Get Quote |
|
| 10MG | 200 | Get Quote |
|
| 25MG | 338 | Get Quote |
|
| 50MG | 498 | Get Quote |
|
| 100MG | 710 | Get Quote |
|
| 500MG | 1431 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameHBF-0259
-
NoteResearch use only, not for human use.
-
Brief DescriptionHBF-0259 is an inhibitors of hepatitis B virus surface antigen (HBsAg) secretion with an EC50 of 11.3 μM and a CC50 value of >50 μM in HepG2.2.15 cells.
-
DescriptionHBF-0259 is an inhibitors of hepatitis B virus surface antigen (HBsAg) secretion with an EC50 of 11.3 μM and a CC50 value of >50 μM in HepG2.2.15 cells. HBF-0259 had a EC50 of approximately 1.5 microM in a secondary, HBV-expressing cell line, with a concentration that exhibited 50% cytotoxicity of >50 microM. The equilibrium concentration of HBF-0259 in aqueous solution at physiological pH was 15 to 16 microM; the selective index was thus >9.
-
In VitroHBF-0259 (0.0158-50.0 μM) inhibits the HBsAg secretion (EC50=1.5 μM) in HepDE19 cells, with an CC50 of >50 μM.HBF-0259 (2-8 μM) significantly reduces the abundance of both L and M in the supernatants of HepG2.2.15 cells.
-
In Vivo——
-
SynonymsHBF 0259 | HBF0259
-
PathwayImmunology/Inflammation
-
TargetAntiviral
-
RecptorHIV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number957011-15-3
-
Formula Weight364.21
-
Molecular FormulaC16H12Cl2FN5
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (274.57 mM)
-
SMILESFc1cccc(Cl)c1C1CC(Nc2nnnn12)c1ccc(Cl)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.John O Link, et al. Clinical targeting of HIV capsid protein with a long-acting small molecule. Nature. 2020 Jul 1.
molnova catalog
related products
-
Tyrosine kinase-IN-7
Tyrosine kinase-IN-7 is a potent inhibitor of the tyrosine kinase EGFR, inhibiting EGFR(WT) and EGFR(T790M) and showing anti-cancer and anti-tumor activity in a variety of cancer cell lines.
-
Oxytetracycline Hydr...
Oxytetracycline Hydrochloride is a tetracycline derivative produced by Streptomyces rimosus with antimicrobial activity.
-
Nepasaikosaponin K
Nepasaikosaponin K is a small molecule compound isolated from Chaikosaponin root with anti-influenza and antiviral activity and can be used in the study of viral infections.
